Jasper Therapeutics (JSPR) Institutional Ownership $5.51 +0.17 (+3.18%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)CurrentInstitutional OwnershipPercentage79.85%Number ofInstitutional Buyers(last 12 months)27TotalInstitutional Inflows(last 12 months)$66.53MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$751.01M Get JSPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data JSPR Institutional Buying and Selling by Quarter Jasper Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails12/26/2024JPMorgan Chase & Co.16,391$308K0.0%+239.8%0.109% 11/27/2024Franklin Resources Inc.579,636$10.90M0.0%-17.0%3.864% 11/19/2024Barclays PLC16,146$304K0.0%+320.7%0.108% 11/16/2024Geode Capital Management LLC257,416$4.84M0.0%-0.9%1.704% 11/15/2024Barclays PLC16,146$304K0.0%+320.7%0.107% 11/15/2024Jane Street Group LLC13,354$251K0.0%N/A0.088% 11/15/2024Wellington Management Group LLP23,759$447K0.0%N/A0.157% 11/15/2024State Street Corp214,883$4.04M0.0%+12.3%1.423% 11/15/2024Samsara BioCapital LLC584,642$11.00M2.1%+11.4%3.872% 11/15/2024Ikarian Capital LLC55,175$1.04M0.1%-47.5%0.365% Get the Latest News and Ratings for JSPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024Braidwell LP483,300$9.09M0.3%N/A3.201% 11/14/2024Verition Fund Management LLC25,353$477K0.0%N/A0.168% 11/14/2024Ally Bridge Group NY LLC399,466$7.51M4.0%+82.7%2.645% 11/14/2024MetLife Investment Management LLC6,874$129K0.0%+129.1%0.046% 11/13/2024Great Point Partners LLC322,380$6.06M1.8%-19.8%2.135% 11/13/2024BNP Paribas Financial Markets2,512$47K0.0%+208.6%0.017% 11/13/2024FMR LLC38,361$722K0.0%N/A0.254% 10/30/2024AlphaCentric Advisors LLC17,500$329K0.2%N/A0.116% 10/29/2024Fernwood Investment Management LLC52,897$995K0.3%+6.9%0.351% 10/16/2024 Wolff Wiese Magana LLC3,146$59K0.0%N/A0.021% 8/14/2024Great Point Partners LLC402,015$9.13M1.7%-1.4%2.669% 8/14/2024Ally Bridge Group NY LLC218,614$4.96M3.0%-24.6%1.451% 8/8/2024American Century Companies Inc.14,204$322K0.0%+27.1%0.094% 8/1/2024Rhumbline Advisers13,231$300K0.0%N/A0.088% 7/26/2024Bank of New York Mellon Corp32,579$740K0.0%N/A0.216% 5/29/2024Opaleye Management Inc.435,573$12.79M2.8%-89.1%2.892% 5/20/2024Virtu Financial LLC10,410$306K0.0%N/A0.069% 5/17/2024Ikarian Capital LLC105,175$3.09M0.3%N/A0.698% 5/16/2024Kingdon Capital Management L.L.C.497,000$14.59M1.6%-86.0%3.300% 5/14/2024Qiming U.S. Ventures Management LLC928,964$27.27M30.4%-89.1%6.168% 5/14/2024StemPoint Capital LP129,211$3.79M1.0%N/A0.858% 5/10/2024Vanguard Group Inc.612,745$17.99M0.0%-85.0%4.069% 5/8/2024Russell Investments Group Ltd.79,811$2.34M0.0%N/A0.530% 5/7/2024Concurrent Investment Advisors LLC20,409$599K0.0%N/A0.136% 5/3/2024Carlyle Group Inc.1,066,189$31.30M2.0%-87.8%7.080% 3/18/2024Kingdon Capital Management L.L.C.3,540,000$2.79M0.3%+16.4%31.720% 2/15/2024Opaleye Management Inc.3,985,340$3.14M0.8%N/A35.717% 2/7/2024Ieq Capital LLC54,500$43K0.0%N/A0.488% 2/7/2024Monaco Asset Management SAM249,563$197K0.1%N/A2.236% 2/5/2024Fernwood Investment Management LLC494,706$390K0.1%+8.8%4.433% The #1 Crypto for AI (Ad)We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW.11/13/2023Mariner LLC652,749$457K0.0%-8.7%0.589% 11/9/2023Cowen AND Company LLC200,393$140K0.0%N/A0.181% 11/8/2023Forefront Analytics LLC110,792$78K0.0%+59.7%0.100% 10/30/2023Summit Trail Advisors LLC65,000$46K0.0%N/A0.059% 8/15/2023Sphera Funds Management LTD.4,274,008$5.86M0.9%+5.7%3.874% 8/14/2023Jefferies Financial Group Inc.489,884$671K0.0%N/A0.444% 6/1/2023Prelude Capital Management LLC54,500$99K0.0%N/A0.049% 5/16/2023Ally Bridge Group NY LLC2,517,232$4.56M6.0%N/A2.301% 5/16/2023BVF Inc. IL9,900,000$17.92M0.7%N/A9.051% 5/15/2023Affinity Asset Advisors LLC476,948$863K0.3%N/A0.436% 5/15/2023Kingdon Capital Management L.L.C.3,040,000$5.50M1.0%+463.0%2.779% 5/15/2023RTW Investments LP2,329,809$4.22M0.1%N/A2.130% 5/12/2023Forefront Analytics LLC30,290$55K0.0%-73.4%0.028% 5/5/2023Carlyle Group Inc.8,761,891$15.77M0.5%N/A8.011% 5/3/2023Jump Financial LLC33,074$60K0.0%N/A0.030% 4/25/2023Qiming U.S. Ventures Management LLC8,519,648$15.42M18.7%+45.6%7.789% 2/13/2023Forefront Analytics LLC114,000$55K0.0%-4.8%0.300% 2/7/2023Fernwood Investment Management LLC454,706$220K0.1%+53.1%1.197% 11/14/2022Forefront Analytics LLC119,800$94K0.1%+246.0%0.327% 11/9/2022Fernwood Investment Management LLC297,080$234K0.1%N/A0.810% 5/10/2022Sectoral Asset Management Inc.675,000$2.40M0.4%N/A1.782% 5/9/2022Forefront Analytics LLC32,550$118K0.0%N/A0.086% 4/27/2022Vahanian & Associates Financial Planning Inc.10,000$36K0.1%-60.0%0.026% 2/15/2022Kingdon Capital Management L.L.C.540,000$4.24M0.5%N/A1.427% 2/2/2022Grace Capital218,110$1.71M1.0%N/A0.576% 1/28/2022Vahanian & Associates Financial Planning Inc.25,000$196K0.2%N/A0.066% 11/16/2021Citadel Advisors LLC3,005,035$29.22M0.0%N/A8.228% 11/15/2021Tudor Investment Corp Et Al20,000$205K0.0%N/A0.055% 11/15/2021Abingworth LLP5,628,558$58.03M13.2%N/A15.412% (Data available from 1/1/2016 forward) JSPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of JSPR shares? During the previous two years, 44 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Carlyle Group Inc. ($31.30M), Qiming U.S. Ventures Management LLC ($27.27M), Vanguard Group Inc. ($17.99M), BVF Inc. IL ($17.92M), Kingdon Capital Management L.L.C. ($14.59M), Opaleye Management Inc. ($12.79M), and Samsara BioCapital LLC ($11.00M).Learn more on JSPR's institutional investors. What percentage of Jasper Therapeutics stock is owned by institutional investors? 79.85% of Jasper Therapeutics stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings. Which institutional investors have been buying Jasper Therapeutics stock? Of the 39 institutional investors that purchased Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($9.90M), Carlyle Group Inc. ($8.76M), Opaleye Management Inc. ($3.99M), Kingdon Capital Management L.L.C. ($3M), Ally Bridge Group NY LLC ($2.70M), Qiming U.S. Ventures Management LLC ($2.67M), and RTW Investments LP ($2.33M). How much institutional buying is happening at Jasper Therapeutics? Institutional investors have bought a total of 36,561,721 shares in the last 24 months. This purchase volume represents approximately $608.55M in transactions. Which Jasper Therapeutics major shareholders have been selling company stock? Of the 12 institutional investors that sold Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Carlyle Group Inc. ($7.70M), Qiming U.S. Ventures Management LLC ($7.59M), Opaleye Management Inc. ($3.55M), Vanguard Group Inc. ($3.48M), Kingdon Capital Management L.L.C. ($3.04M), Franklin Resources Inc. ($118.90K), and Forefront Analytics LLC ($89.51K). How much institutional selling is happening at Jasper Therapeutics? Institutional investors have sold a total of 25,838,860 shares in the last 24 months. This volume of shares sold represents approximately $752.99M in transactions. Related Companies Neumora Therapeutics Major Shareholders KalVista Pharmaceuticals Major Shareholders Aura Biosciences Major Shareholders Organogenesis Major Shareholders Eton Pharmaceuticals Major Shareholders Valneva Major Shareholders Prime Medicine Major Shareholders Korro Bio Major Shareholders REGENXBIO Major Shareholders Contineum Therapeutics Major Shareholders This page (NASDAQ:JSPR) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
